Although obesity is associated with increasing insulin resistance and pancreatic β-cell dysfunction, it remains unclear whether weight control during pregnancy, as recommended by the Institute of Medicine, would reduce the risk of GDM or the need for insulin therapy (34). Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.